Medgenics, Inc. News Headlines

MDGN 
$5.01
*  
0.11
2.24%
Get MDGN Alerts
*Delayed - data as of Oct. 23, 2014  -  Find a broker to begin trading MDGN now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
New Positive Clinical Data Supports Quest Towards Orphan Designations
10/17/2014 6:45:00 AM - Seeking Alpha


Medgenics Q3 14 Earnings Conference Call At 9:00 AM ET
10/15/2014 8:00:00 AM - RTT News


Pre-Market Earnings Report for October 15, 2014 : BAC, BLK, PNC, ASML, SCHW, STJ, KEY, CBSH, MTG, IGTE, MDGN
10/14/2014 4:00:03 PM - NASDAQ.com News


BCLI Gets A Pat On The Back, OXGN At Work, MDGN Rises After Hours
10/8/2014 12:51:00 AM - RTT News


HCI Group: The Wizards Of Tampa, Part III
9/24/2014 2:40:48 PM - SeekingAlpha


Tuesday 6/17 Insider Buying Report: MFRM, MDGN
6/17/2014 2:34:13 PM - BNK Invest


Medgenics Looking To Exploit Orphan Drug Market With Its Novel Biopump Protein Therapy Technology
6/11/2014 9:49:00 AM - Seeking Alpha


New Management Pushes Medgenics To Forefront Of Gene Therapy
9/23/2013 2:03:00 PM - Seeking Alpha


Bill Gross Buys Pimco Fund Again, Plus Insiders Buy at Hallmark Financial and Medgenics
9/20/2013 9:49:00 AM - Minyanville


Medgenics: Overlooked Biotech Stock Could Be Good Risk/Reward Investment
9/20/2013 9:46:00 AM - Seeking Alpha


Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low
9/3/2013 11:34:28 AM - GuruFocus


The Jury Is Still Out On The Risky NS5B Drugs
2/14/2013 12:56:00 PM - Seeking Alpha


Idenix Failure Clears The Way For Medgenics' Hepatitis C Blockbuster
2/11/2013 5:50:00 PM - Seeking Alpha


Medgenics Launches Trial For Multibillion-Dollar Holy Grail Indication Against Hepatitis C
1/30/2013 5:21:00 PM - Seeking Alpha


New Data Presented By Medgenics Positions It As Leader In $20 Billion Kidney Disease Market
11/8/2012 6:06:00 PM - Seeking Alpha


Tracking The Investment Profile Of A Proven Winner
9/25/2012 8:53:00 AM - Seeking Alpha


Medgenics' Bulging Pipeline Of Blockbuster Indications Takes On Big Pharma's Harmful Drugs
9/18/2012 2:35:00 PM - Seeking Alpha


Protalix Reinforces Case For Taliglucerase Alfa; Healthcare Sector Volume Keeps Rising
2/10/2012 8:55:00 AM - Seeking Alpha


Medgenics' Disruptive Biotechnology Is One To Watch
2/8/2012 11:46:00 AM - Seeking Alpha